Global Equine Rabies Immunoglobulin (ERIG) Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Equine Rabies Immunoglobulin (ERIG) Market Research Report 2024
Equine rabies immunoglobulin (ERIG) is a biological product derived from horse blood plasma used as passive immunity against rabies virus.
According to Mr Accuracy reports new survey, global Equine Rabies Immunoglobulin (ERIG) market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Equine Rabies Immunoglobulin (ERIG) market research.
The market for equine rabies immunoglobulin is driven by its role as a protective treatment for rabies exposure, especially in regions where human rabies immune globulin (HRIG) may not be readily available. ERIG is used in combination with the rabies vaccine to prevent rabies infection. As rabies prevention remains a priority in animal healthcare and public health, the market for ERIG is expected to continue.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Equine Rabies Immunoglobulin (ERIG) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Serum China
Lanzhou Institute of Biological Products
Wuhan Institute of Biological Products
Premium Serums
Haffkine Bio-Pharmaceutical
Bharat Serums
Segment by Type
1500IU
1000IU
400IU
Other
Category II Exposure
Category III Exposure
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Equine Rabies Immunoglobulin (ERIG) report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports new survey, global Equine Rabies Immunoglobulin (ERIG) market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Equine Rabies Immunoglobulin (ERIG) market research.
The market for equine rabies immunoglobulin is driven by its role as a protective treatment for rabies exposure, especially in regions where human rabies immune globulin (HRIG) may not be readily available. ERIG is used in combination with the rabies vaccine to prevent rabies infection. As rabies prevention remains a priority in animal healthcare and public health, the market for ERIG is expected to continue.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Equine Rabies Immunoglobulin (ERIG) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Serum China
Lanzhou Institute of Biological Products
Wuhan Institute of Biological Products
Premium Serums
Haffkine Bio-Pharmaceutical
Bharat Serums
Segment by Type
1500IU
1000IU
400IU
Other
Segment by Application
Category II Exposure
Category III Exposure
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Equine Rabies Immunoglobulin (ERIG) report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices